Skip to content
October 6, 2026
  • Institutional Betrayal: HHS’s Failure to Decarbonize the Healthcare Industry (Part 1)
  • Federal Cuts Gut Food Banks as They Face Record Demand
  • Your Guide to the Best Places to Buy Used Lab Equipment
  • Why the Future of IDR Depends on Smarter Technology

Medical Article

Newsletter
Random News
Headlines
  • Centros de salud enfrentan riesgos por la caída de la financiación del gobierno

    1 year ago
  • Trump’s Health Fraud Focus at Odds With Past Pardons

    2 years ago
  • How Have Hospitals Fared Financially So Far in 2024?

    2 years ago
  • The Overlooked Pillar of Clinical Care: Physical Therapists

    2 years ago
  • Debate Over Pediatric Gender-Affirming Care Intensifies Following New HHS Report

    11 months ago
  • Flawed Report Aims to Undercut Established Research on Abortion Pill Safety, Plus How a Federal Initiative to Study Autism May Overemphasize Environmental Toxins — The Monitor

    1 year ago
  • Other

Epic Systems Slammed by Antitrust Lawsuit

2 years ago01 mins

Particle Health accuses Epic Systems of antitrust violations in the EHR market

Read More
  • Medicine

Will CMS’ Last-Minute Medicaid Work Requirement Changes Cause More Harm?

4 months ago01 mins

Healthcare advocates warn that a new CMS rule on Medicaid work requirement exemptions could increase red tape and cause eligible people to lose coverage. The post Will CMS’ Last-Minute Medicaid Work Requirement Changes Cause More Harm? appeared first on MedCity News.

Read More
  • Medicine

Beyond Drugs: Blood-Based Therapies in Sickle Cell Disease and Beyond

2 years ago01 mins

At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients’ lives, a broad commitment is needed to expand access to transfusion therapies. The post Beyond…

Read More
  • Medicine

Galapagos to Wind Down Cell Therapy Business After Search for a Buyer Comes Up Empty

12 months ago01 mins

Non-binding offers for Galapagos’s cell therapies assets came mostly from financial investors, and none offered sufficient terms or financing to support the business, the company said. Galapagos’s exit from cell therapy work will lead to site closures in Europe, China, and the U.S. The post Galapagos to Wind Down Cell Therapy Business After Search for…

Read More
  • News

A Look at 1115 Waiver Evaluations for Medicaid Payments to Institutions of Mental Disease (IMD) for Substance Use Disorder 

3 months ago01 mins

As SUD IMD waiver evaluations and renewals are becoming available, states face a shifting Medicaid and policy and waiver landscape. This brief examines findings from the first available summative evaluations for SUD IMD waivers and what they show about progress toward meeting goals and milestones.

Read More
  • News

National Vaccination Day, Importance of Vaccines

7 months ago01 mins

The post National Vaccination Day, Importance of Vaccines appeared first on Medifyhome.

Read More
  • Medicine

PBGH Calls on New Congress and Administration to Improve Employee Healthcare in 2 Key Areas

2 years ago01 mins

In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care. The post PBGH Calls on New Congress and Administration to Improve Employee Healthcare in 2 Key Areas appeared first on MedCity News.

Read More
  • Medicine

Preparing Benefits For the Next Wave: Gene Therapy Medications

4 months ago01 mins

The rise of metabolic gene therapies represents a critical juncture for benefits management. These treatments offer genuine hope for patients with serious conditions, but they also pose significant financial challenges.  The post Preparing Benefits For the Next Wave: Gene Therapy Medications appeared first on MedCity News.

Read More
  • Medicine

Genmab to Pay $8B to Get Its Hands on Merus Head & Neck Cancer Drug With Blockbuster Potential

1 year ago01 mins

Merus brings Genmab a bispecific antibody in two pivotal studies for head and neck cancer. Genmab, which had long developed drugs under partnerships with larger companies, is now pursuing a strategy of developing and commercializing medications it fully owns. The post Genmab to Pay $8B to Get Its Hands on Merus Head & Neck Cancer…

Read More
  • Other

Rice, Baylor to Embed Humanities Research Into Trustworthy Health AI

1 year ago01 mins

National Endowment for the Humanities funds Center for Humanities-based Health AI Innovation

Read More
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 808

Recent Posts

  • Prevalence, adherence, and health care resource utilization in schizophrenia
  • MultiCare Health System Takes Platform-Based Approach to Data Orchestration
  • Key Facts About Medigap Enrollment and Premiums for Medicare Beneficiaries
  • Why Several Insurers Are Cutting/Withdrawing Their Earnings Guidance
  • ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024

Categories

  • Articles
  • Medicine
  • News
  • Other
Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.